Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis

N Engl J Med. 1997 Jul 31;337(5):357-63. doi: 10.1056/NEJM199707313370525.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / economics*
  • Anti-Bacterial Agents / therapeutic use*
  • Ceftriaxone / adverse effects
  • Ceftriaxone / economics*
  • Ceftriaxone / therapeutic use*
  • Cephalosporins / adverse effects
  • Cephalosporins / economics
  • Cephalosporins / therapeutic use
  • Cost-Benefit Analysis
  • Decision Trees
  • Doxycycline / adverse effects
  • Doxycycline / economics*
  • Doxycycline / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Injections, Intravenous
  • Lyme Disease / drug therapy*
  • Lyme Disease / economics*
  • Nervous System Diseases / prevention & control
  • Quality of Life
  • Quality-Adjusted Life Years
  • Risk

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Ceftriaxone
  • Doxycycline